1344 Preclinical PK/PD profile, biomarker identification and rationale for indication selection of exoASO-STAT6™, a selective tumor-associated macrophage targeting candidate

MLA

Sushrut Kamerkar, et al. “1344 Preclinical PK/PD Profile, Biomarker Identification and Rationale for Indication Selection of ExoASO-STAT6™, a Selective Tumor-Associated Macrophage Targeting Candidate.” Regular and Young Investigator Award Abstracts, Nov. 2022. EBSCOhost, https://doi.org/10.1136/jitc-2022-sitc2022.1344.

APA

Sushrut Kamerkar, Charan Leng, Kelvin Zhang, Olga Burenkova, Su Chul Jang, Tong Zi, Sílvia Sisó, Kyriakos Economides, Karl Schmidt, Timothy Soos, Dalia Burzyn, & Sriram Sathyanaryanan. (2022). 1344 Preclinical PK/PD profile, biomarker identification and rationale for indication selection of exoASO-STAT6™, a selective tumor-associated macrophage targeting candidate. Regular and Young Investigator Award Abstracts. https://doi.org/10.1136/jitc-2022-sitc2022.1344

Chicago

Sushrut Kamerkar, Charan Leng, Kelvin Zhang, Olga Burenkova, Su Chul Jang, Tong Zi, Sílvia Sisó, et al. 2022. “1344 Preclinical PK/PD Profile, Biomarker Identification and Rationale for Indication Selection of ExoASO-STAT6™, a Selective Tumor-Associated Macrophage Targeting Candidate.” Regular and Young Investigator Award Abstracts, November. doi:10.1136/jitc-2022-sitc2022.1344.